» Authors » Mark J Dunne

Mark J Dunne

Explore the profile of Mark J Dunne including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 607
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Worth C, Nutter P, Salomon-Estebanez M, Auckburally S, Dunne M, Banerjee I, et al.
Digit Health . 2023 Aug; 9:20552076231192011. PMID: 37545627
Background: Children with hypoglycaemia disorders, such as congenital hyperinsulinism (CHI), are at constant risk of hypoglycaemia (low blood sugars) with the attendant risk of brain injury. Current approaches to hypoglycaemia...
2.
Worth C, Dunne M, Salomon-Estebanez M, Harper S, Nutter P, Dastamani A, et al.
Front Endocrinol (Lausanne) . 2022 Nov; 13:1016072. PMID: 36407313
Objective: Continuous Glucose Monitoring (CGM) is gaining in popularity for patients with paediatric hypoglycaemia disorders such as Congenital Hyperinsulinism (CHI), but no standard measures of accuracy or associated clinical risk...
3.
Wakeling M, Owens N, Hopkinson J, Johnson M, Houghton J, Dastamani A, et al.
Nat Genet . 2022 Nov; 54(11):1615-1620. PMID: 36333503
Gene expression is tightly regulated, with many genes exhibiting cell-specific silencing when their protein product would disrupt normal cellular function. This silencing is largely controlled by non-coding elements, and their...
4.
Worth C, Nutter P, Dunne M, Salomon-Estebanez M, Banerjee I, Harper S
Digit Health . 2022 Oct; 8:20552076221129712. PMID: 36276186
Background: Children with congenital hyperinsulinism (CHI) are at constant risk of hypoglycaemia with the attendant risk of brain injury. Current hypoglycaemia prevention methods centre on the prediction of a continuous...
5.
van Albada M, Mohnike K, Dunne M, Banerjee I, Betz S
Front Endocrinol (Lausanne) . 2022 Oct; 13:921357. PMID: 36237195
Congenital hyperinsulinism (CHI), although a rare disease, is an important cause of severe hypoglycemia in early infancy and childhood, causing preventable morbidity and mortality. Prompt diagnosis and appropriate treatment is...
6.
Dastamani A, Yau D, Gilbert C, Morgan K, De Coppi P, Craigie R, et al.
J Endocr Soc . 2022 May; 6(6):bvac033. PMID: 35592516
Context: In focal congenital hyperinsulinism (CHI), localized clonal expansion of pancreatic β-cells causes excess insulin secretion and severe hypoglycemia. Surgery is curative, but not all lesions are amenable to surgery....
7.
Humphries J, Zha J, Burns J, Askari J, Below C, Chastney M, et al.
Matrix Biol . 2022 Apr; 110:16-39. PMID: 35405272
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to its aggressive progression, late detection and lack of druggable driver mutations, which often combine to result in unsuitability for surgical...
8.
Banerjee I, Sajjan R, Estebanez M, Dunne M, Mohnike K, Mohnike W, et al.
J Nucl Med . 2022 Mar; 63(3):493. PMID: 35232880
No abstract available.
9.
Worth C, Harper S, Salomon-Estebanez M, OShea E, Nutter P, Dunne M, et al.
J Med Internet Res . 2021 Aug; 23(10):e26957. PMID: 34435596
Background: Hyperinsulinism (HI) due to excess and dysregulated insulin secretion is the most common cause of severe and recurrent hypoglycemia in childhood. High cerebral glucose use in the early hours...
10.
Salomon-Estebanez M, Yau D, Dunne M, Worth C, Birch S, Walewski J, et al.
Front Endocrinol (Lausanne) . 2020 Dec; 11:614734. PMID: 33312164
[This corrects the article DOI: 10.3389/fendo.2020.00441.].